Drug discovery is a foundational part of business for a pharmaceutical company, one that can unlock new revenue streams and safeguard an organization’s future. However, finding and developing new drugs has traditionally been a costly, time-consuming process involving a lot of regulatory approvals. According to Deloitte, in 2024, research and development (R&D) for a new drug cost an average of $2.23 billion USD. It takes twelve to fourteen years to develop a new drug, so reducing this timeline by even one year could save $159 million per drug. Over a major pharmaceutical pipeline, savings could reach greater than $15…

The post Designing the Best AI Infrastructure for Drug Discovery appeared first on Interconnections - The Equinix Blog.